Bristol-Myers Squibb to Buy Celgene for $74 Billion
Catherine Offord | Jan 3, 2019
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
Image of the Day: Mind Altering
Image of the Day: Mind Altering
A study in rats finds that tiny doses of the psychedelic drug DMT may yield positive effects for anxiety and depression, but there could be downsides too.
A study in rats finds that tiny doses of the psychedelic drug DMT may yield positive effects for anxiety and depression, but there could be downsides too.
Infographic: How Exposure to Cannabis in Utero Affects Development
Andrew Scheyer | Jan 1, 2019
Rodent and human studies have revealed a multitude of effects starting during gestation and lasting into adulthood.
Octopuses On Ecstasy Reveal Commonalities with Humans
Shawna Williams | Sep 21, 2018
Just as in people, the drug stimulates the animals to behave more socially.
Novartis and Sanofi Stockpile Meds in Preparation for Brexit
Ashley Yeager | Aug 3, 2018
If the UK leaves the EU in March without a deal, transport of insulin and other essential drugs could be delayed.
UK to Legalize Medicinal Cannabis
Catherine Offord | Jul 27, 2018
Patients will be able to access the drug with a prescription, and there are no plans to allow for recreational use.
Antibody-Drug Combo Approved
Dan Cossins | Feb 25, 2013
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
Comment on New NIH Center
Megan Scudellari | Feb 10, 2012
Input lines are open for the National Institute of Substance Use and Addiction Disorders.
Novel Cystic Fibrosis Drug Approved
Megan Scudellari | Feb 1, 2012
After a lightning-fast approval, the first medicine to treat an underlying cause of the disorder hits the market.
Drug Headlines of 2011
Hannah Waters | Dec 20, 2011
A list of this year’s newsworthy successes—and failures—in drug development